The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial

Journal Title: BMC Women's Health - Year 2012, Vol 12, Issue

Abstract

Costs of in vitro fertilisation (IVF) are high, which is partly due to the use of follicle stimulating hormone (FSH). FSH is usually administered in a standard dose. However, due to differences in ovarian reserve between women, ovarian response also differs with potential negative consequences on pregnancy rates. A Markov decision-analytic model showed that FSH dose individualisation according to ovarian reserve is likely to be cost-effective in women who are eligible for IVF. However, this has never been confirmed in a large randomised controlled trial (RCT). The aim of the present study is to assess whether an individualised FSH dose regime based on an ovarian reserve test (ORT) is more cost-effective than a standard dose regime.

Authors and Affiliations

Theodora C van Tilborg, Marinus JC Eijkemans, Joop SE Laven, Carolien AM Koks, Jan Peter de Bruin, Gabrielle J Scheffer, Ron JT van Golde, Kathrin Fleischer, Annemieke Hoek, Annemiek W Nap, Walter KH Kuchenbecker, Petra A Manger, Egbert A Brinkhuis, Arne M van Heusden, Alexander V Sluijmer, Arie Verhoeff, Marcel HA van Hooff, Jaap Friederich, Jesper MJ Smeenk, Janet Kwee, Harold R Verhoeve, Cornelis B Lambalk, Frans M Helmerhorst, Fulco van der Veen, Ben Willem J Mol, Helen L Torrance, Frank JM Broekmans

Keywords

Related Articles

Sexual function and chemotherapy in postmenopausal women with breast cancer

This cross-sectional, nested cohort study assessed Female Sexual Function Index (FSFI) scores in postmenopausal women with breast cancer receiving primary chemotherapy.

Evaluation of dietary intake of lactating women in China and its potential impact on the health of mothers and infants

Optimal nutrition for lactating mothers is importance for mother and infants’ health and well-being. We determined the nutrient intake and dietary changes during the first 3-month of lactation, and its potential...

Treatment of endometriosis in different ethnic populations: a meta-analysis of two clinical trials

Approaches to the treatment of endometriosis vary worldwide, but studies comparing endometriosis medications in different ethnic groups are rare. A systematic literature search identified two studies directly comparing d...

The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial

Costs of in vitro fertilisation (IVF) are high, which is partly due to the use of follicle stimulating hormone (FSH). FSH is usually administered in a standard dose. However, due to differences in ovarian reserve between...

Menopause and the influence of culture: another gap for Indigenous Australian women?

There is great variation in experience of menopause in women around the world. The purpose of this study was to review current understanding of Australian Aboriginal and Torres Strait Islander (Indigenous) women’...

Download PDF file
  • EP ID EP679507
  • DOI  10.1186/1472-6874-12-29
  • Views 65
  • Downloads 0

How To Cite

Theodora C van Tilborg, Marinus JC Eijkemans, Joop SE Laven, Carolien AM Koks, Jan Peter de Bruin, Gabrielle J Scheffer, Ron JT van Golde, Kathrin Fleischer, Annemieke Hoek, Annemiek W Nap, Walter KH Kuchenbecker, Petra A Manger, Egbert A Brinkhuis, Arne M van Heusden, Alexander V Sluijmer, Arie Verhoeff, Marcel HA van Hooff, Jaap Friederich, Jesper MJ Smeenk, Janet Kwee, Harold R Verhoeve, Cornelis B Lambalk, Frans M Helmerhorst, Fulco van der Veen, Ben Willem J Mol, Helen L Torrance, Frank JM Broekmans (2012). The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial. BMC Women's Health, 12(), -. https://europub.co.uk/articles/-A-679507